Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12
Closed -$865 492
2024
Q4
$865 Sell
12
-8
-40% -$625 ﹤0.01% 944
2024
Q3
$1.63K Hold
20
﹤0.01% 1263
2024
Q2
$1.49K Hold
20
﹤0.01% 921
2024
Q1
$1.56K Hold
20
﹤0.01% 906
2023
Q4
$1.43K Sell
20
-5
-20% -$348 ﹤0.01% 771
2023
Q3
$1.74K Hold
25
﹤0.01% 776
2023
Q2
$2.02K Buy
25
+5
+25% +$409 ﹤0.01% 760
2023
Q1
$1.61K Sell
20
-8
-29% -$644 ﹤0.01% 781
2022
Q4
$2.1K Hold
28
﹤0.01% 760
2022
Q3
$2K Hold
28
﹤0.01% 765
2022
Q2
$1.94K Buy
+28
New +$2.08K ﹤0.01% 826
2022
Q1
Sell
-127
Closed -$10K 589
2021
Q4
$10K Sell
127
-99
-44% -$7.28K 0.01% 694
2021
Q3
$18K Buy
226
+24
+12% +$1.8K 0.01% 633
2021
Q2
$14K Buy
+202
New +$13.5K 0.01% 617

Other funds holding HOLX

Eagle Bay Advisors's HOLX Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Hologic (HOLX) in Q1 2025, closing a stake of 12 shares — an estimated $865 sold.

Eagle Bay Advisors first reported a position in HOLX in Q2 2021 and held it in 14 quarters. The position peaked at $18K in Q3 2021. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 12 Hologic shares in Q1 2025, an estimated $865.
  • Eagle Bay Advisors first reported a position in Hologic in Q2 2021 and held it in 14 quarters.
  • Eagle Bay Advisors's Hologic position peaked at $18K in Q3 2021.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.